2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Yaghmur A et al. Self-assembled nanostructures of fully hydrated monoelaidin-elaidic acid and monoelaidin-oleic acid systems. 2012 Langmuir pmid:22690845
Pepe D et al. Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. 2012 Int J Pharm pmid:22692080
Mistry PH et al. Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures. 2012 Nanomedicine (Lond) pmid:22709346
Angelov B et al. Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study. 2012 J Phys Chem B pmid:22720820
Zhen G et al. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro. 2012 Mol. Pharm. pmid:22794355
Jain V et al. Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy. 2012 Biomaterials pmid:22809646
Su X et al. [Preparation and physiochemical properties of curcumin-loaded lipid cubic liquid crystalline nanoparticles]. 2012 Zhong Yao Cai pmid:22822677
Nilsson C et al. Characterization of oil-free and oil-loaded liquid-crystalline particles stabilized by negatively charged stabilizer citrem. 2012 Langmuir pmid:22831645
Kulkarni CV Lipid crystallization: from self-assembly to hierarchical and biological ordering. 2012 Nanoscale pmid:22899223
Canfield LM et al. Incorporation of beta-carotene into mixed micelles. 1990 Meth. Enzymol. pmid:2292951
Issa JP et al. Biological evaluation of the bone healing process after application of two potentially osteogenic proteins: an animal experimental model. 2012 Gerodontology pmid:22970792
Labahn J et al. Vapor diffusion-controlled meso crystallization of membrane proteins. 2012 Methods Mol. Biol. pmid:22976020
Vicentini FT et al. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. 2013 Eur J Pharm Biopharm pmid:23010565
Réeff J et al. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. 2013 Drug Dev Ind Pharm pmid:23078519
López CA et al. Amylose folding under the influence of lipids. 2012 Carbohydr. Res. pmid:23128420
Hosmer JM et al. Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride. 2013 Pharm. Res. pmid:23135821
Thapa RK and Yoo BK Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. 2014 J Dermatolog Treat pmid:23210668
Squires AM et al. Preparation of films of a highly aligned lipid cubic phase. 2013 Langmuir pmid:23347289
Bilalov A et al. Embedding DNA in surfactant mesophases: the phase diagram of the ternary system dodecyltrimethylammonium-DNA/monoolein/water in comparison to the DNA-free analogue. 2013 J Colloid Interface Sci pmid:23347998
Zhou Y et al. Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts. 2014 Drug Dev Ind Pharm pmid:23350691